Cited by

• The relative infrequency and low levels of neutralising and immunoprecipitating antibody to herpes simplex viruses types 1 and 2 in patients with a history of recurrent herpes genitalis.

  Woodman CB, Stocker D, Sugrue D, Desberbasques M, Hartley CE, Fuller A, Buchan A, Skinner GR. Woodman CB, et al. Med Microbiol Immunol. 1983;171(4):243-50. doi: 10.1007/BF02123498. Med Microbiol Immunol. 1983. PMID: 6304481
• Purification of the structural proteins of herpes simplex virus type 1 by reverse-phase high performance liquid chromatography.

  Whittaker GR, Meredith DM. Whittaker GR, et al. Arch Virol. 1990;114(3-4):271-6. doi: 10.1007/BF01310757. Arch Virol. 1990. PMID: 2173528
• Antibody reactivity with Skinner HSV vaccine.

  Muniu EM, Durham J, Shariff D, Hartley CE, Fuller A, Melling J, Wiblin C, Wilkins G, Buchan A, Skinner GR. Muniu EM, et al. Med Microbiol Immunol. 1987;176(6):315-27. doi: 10.1007/BF00194891. Med Microbiol Immunol. 1987. PMID: 2828898
• Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses.

  Paladino P, Collins SE, Mossman KL. Paladino P, et al. PLoS One. 2010 Apr 29;5(4):e10428. doi: 10.1371/journal.pone.0010428. PLoS One. 2010. PMID: 20454685 Free PMC article.
• Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex.

  Lukàcs N, Thiel HJ, Mettenleiter TC, Rziha HJ. Lukàcs N, et al. J Virol. 1985 Jan;53(1):166-73. doi: 10.1128/JVI.53.1.166-173.1985. J Virol. 1985. PMID: 2578194 Free PMC article.